Rainbow Genomics Launches Privacy-Protected Genetic Testing with the International Genetic Counseling Center

Compliance with US regulatory guidelines and appointments by Rainbow’s physicians and genetic consultants allow for uncompromising protection of patient privacy

SAN FRANCISCO, CA, UNITED STATES, Sept. 20, 2022 /EINPresswire.com/ — US and Hong Kong-based Rainbow Genomics is launching privacy-protected genetic testing with the genetic counseling team at the Hong Kong-based International Genetic Counseling Center. The privacy paradigm covers all Rainbow products including whole genome sequencing, whole exome sequencing, cancer, cardiovascular disease and carrier genetic testing.

Genetic data is personal and can provide insight into patients’ ethnicity, family medical history, and likelihood of developing certain diseases. Unlike the United States, where laws protecting genetic data prohibit third parties, including employers and insurance companies, from accessing patient data, genetic test results are not protected in the same way in many Asian countries. As a result, many patients are reluctant to seek necessary genetic testing, delaying their diagnosis and treatment.

Also Read :  Affecting Up to 216,000 Studies – Popular Genetic Method Found To Be Deeply Flawed

In the absence of comprehensive legislation protecting patients, Rainbow Genomics has established a standard of practice in full compliance with US regulations, including the Genetic Information Nondiscrimination Act (GINA) and the Health Insurance Portability and Accountability Act (HIPAA).

Compliance with these regulations means that health insurance companies or employers cannot receive patient data and reports from Rainbow. In addition, patient health information will not be shared without the patient’s written consent.

The entire clinical process, including test ordering, results reporting, and genetic counseling, is conducted in the strictest confidence by Rainbow’s board-certified medical directors and board-licensed genetic counselors. Consistent with these regulatory standards, Rainbow offers a high level of patient privacy not typically matched by other clinics and laboratories in the region.

Also Read :  LumiraDx named by Frost & Sullivan as the 2022 Europe Technology Innovation Leader in the Microfluidics Point of Care Diagnostics Industry

About Rainbow Genomics

Rainbow Genomics (www.rainbowgenomics.com) is committed to providing clinically validated genomic and proteomic tests for Asian, Caucasian, multiracial and local minorities. The company provides physicians with high diagnostic success and enables timely treatment of patients who can benefit from immediate medical interventions.

Leveraging a multi-technology platform approach including proteomics, whole genome, whole exome, RNA, long read, methylation, single cell and Sanger sequencing, high resolution microarray testing and high density DNA array genotyping, and by several international Collaborating, Rainbow Genomics delivers diagnostic yield that meets or exceeds the highest standards reported by leading US and European medical institutions.

All Rainbow Genomics tests are performed in CLIA-certified and CAP-accredited clinical laboratories with high complexity. Patient privacy is protected by Rainbow’s HIPAA-compliant clinical testing process.

About the International Genetic Counseling Center

The International Genetic Counseling Center offers services in English, Cantonese and Mandarin. Genetic counseling practices comply with ACMG (US) and ACGS (UK) guidelines, the US Non-Discrimination of Genetic Information Act and HIPAA regulations, GLP, ISO 15189, CAP and CLIA requirements.

Also Read :  Time for Universal Germline Genetic Testing in Breast Cancer

rainbow genomics
+852 3481 0977
[email protected]

Source link